Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher K Rayner

Showing results (41-50 of 251) with videos related to

Pageof 26
Sort By:
Acta Diabetologica|August 11, 2016
Reactive hypoglycaemia with seizure following intraduodenal glucose infusion in a patient with type 2 diabetesChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Expert Opinion on Pharmacotherapy|May 14, 2013
Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectivesJulie E Stevens, Karen L Jones, Christopher K Rayner, et al.
Pain|August 31, 2007
The diabetic gut--both aching and unfeeling?Christopher K Rayner, Karen L Jones, Ashley L Blackshaw, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2016
Letter to the Editor: One-Hour Postload Hyperglycemia is a Stronger Predictor of Type 2 Diabetes than Impaired Fasting GlucoseChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Expert Review of Gastroenterology & Hepatology|December 10, 2015
Novel insights into the effects of diabetes on gastric motilityChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
The Lancet. Diabetes & Endocrinology|August 1, 2022
Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetesRyan J Jalleh, Christopher K Rayner, Karen L Jones, et al.
Obesity (Silver Spring, Md.)|July 27, 2022
Glucagon-like peptide-1 receptor agonists, weight loss, and gastric emptying: have I gut news for youRyan J Jalleh, Christopher K Rayner, Karen L Jones, et al.
Diabetologia|August 13, 2017
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathyChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Peptides|March 26, 2013
Glucagon-like peptides 1 and 2 in health and disease: a reviewChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Diabetes, Obesity & Metabolism|October 27, 2017
Targeting postprandial glycaemia in children with diabetes: Opportunities and challengesMyfanwy C Geyer, Christopher K Rayner, Michael Horowitz, et al.
Pageof 26

Showing results (41-50 of 251) with videos related to

Sort By:
Pageof 26
Acta Diabetologica|August 11, 2016
Reactive hypoglycaemia with seizure following intraduodenal glucose infusion in a patient with type 2 diabetesChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Expert Opinion on Pharmacotherapy|May 14, 2013
Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectivesJulie E Stevens, Karen L Jones, Christopher K Rayner, et al.
Pain|August 31, 2007
The diabetic gut--both aching and unfeeling?Christopher K Rayner, Karen L Jones, Ashley L Blackshaw, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2016
Letter to the Editor: One-Hour Postload Hyperglycemia is a Stronger Predictor of Type 2 Diabetes than Impaired Fasting GlucoseChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Expert Review of Gastroenterology & Hepatology|December 10, 2015
Novel insights into the effects of diabetes on gastric motilityChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
The Lancet. Diabetes & Endocrinology|August 1, 2022
Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetesRyan J Jalleh, Christopher K Rayner, Karen L Jones, et al.
Obesity (Silver Spring, Md.)|July 27, 2022
Glucagon-like peptide-1 receptor agonists, weight loss, and gastric emptying: have I gut news for youRyan J Jalleh, Christopher K Rayner, Karen L Jones, et al.
Diabetologia|August 13, 2017
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathyChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Peptides|March 26, 2013
Glucagon-like peptides 1 and 2 in health and disease: a reviewChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Diabetes, Obesity & Metabolism|October 27, 2017
Targeting postprandial glycaemia in children with diabetes: Opportunities and challengesMyfanwy C Geyer, Christopher K Rayner, Michael Horowitz, et al.
Pageof 26